PCRX

PCRX Deferred Revenue

$0.00Quarterly · USD

Period ending:

PCRX FY Deferred RevenueUSD
PCRX FY Deferred Revenue2008-12-31: $2.05M2009-12-31: $2.35M2010-12-31: $2.27M2011-12-31: $13.05M2012-12-31: $972.00K2013-12-31: $1.01M2014-12-31: $1.43M2015-12-31: $1.43M2016-12-31: $595.00K2017-12-31: $102.00K2018-12-31: $0.002019-12-31: $0.002020-12-31: $0.002021-12-31: $0.002022-12-31: $0.002023-12-31: $0.002024-12-31: $0.002025-12-31: $0.00$13.05M$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
102,000
595,000
1,426,000
1,426,000
1,008,000
972,000
13,054,000
2,267,000
2,346,000
2,046,000

Compare deferred revenue

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.